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Abstract
The introduction ten years ago of RNA interference (RNAi) as a tool for molecular exploration in Trypanosoma brucei has led
to a surge in our understanding of the pathogenesis and biology of this human parasite. In particular, a genome-wide RNAi
screen has recently been combined with next-generation Illumina sequencing to expose catalogues of genes associated
with loss of fitness in distinct developmental stages. At present, this technology is restricted to RNAi-positive protozoan
parasites, which excludes T. cruzi, Leishmania major, and Plasmodium falciparum. Therefore, elucidating the mechanism of
RNAi and identifying the essential components of the pathway is fundamental for improving RNAi efficiency in T. brucei and
for transferring the RNAi tool to RNAi-deficient pathogens. Here we used comparative genomics of RNAi-positive and -
negative trypanosomatid protozoans to identify the repertoire of factors in T. brucei. In addition to the previously
characterized Argonaute 1 (AGO1) protein and the cytoplasmic and nuclear Dicers, TbDCL1 and TbDCL2, respectively, we
identified the RNA Interference Factors 4 and 5 (TbRIF4 and TbRIF5). TbRIF4 is a 39-59 exonuclease of the DnaQ superfamily
and plays a critical role in the conversion of duplex siRNAs to the single-stranded form, thus generating a TbAGO1-siRNA
complex required for target-specific cleavage. TbRIF5 is essential for cytoplasmic RNAi and appears to act as a TbDCL1
cofactor. The availability of the core RNAi machinery in T. brucei provides a platform to gain mechanistic insights in this
ancient eukaryote and to identify the minimal set of components required to reconstitute RNAi in RNAi-deficient parasites.
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Introduction
RNA interference (RNAi) was first described in 1998 and within
a short period of time tremendously facilitated the analysis of gene
function, especially in organisms where classical genetic approach-
es are not available. This is particularly evident in the human
pathogen Trypanosoma brucei, where RNAi has become a primary
tool to interrogate its biology aided by the availability of an
inducible and heritable system [1,2]. The effectiveness of RNAi in
T. brucei is documented by over 500 publications in the past ten
years and the availability of the genome sequence has opened up
the possibility for genome-wide RNAi screens [1]. In particular,
the very recently introduced RIT-Seq method (RNA Interference
Target Sequencing) took advantage of the power of genome-wide
RNAi screens and combined it with the strength and depth of
next-generation Illumina sequencing [3]. This strategy provided
the scientific community with a catalogue of genes whose knock-
down is detrimental to the parasite under a variety of develop-
mental conditions and is likely to find numerous applications in
RNAi-positive parasites.
Although RNAi has flourished immensely in T. brucei,a s
highlighted by the above brief synopsis, it was rather disappointing
to recognize both experimentally and at the genome sequence
level that other protozoan parasites with a major impact on
mankind, including T. cruzi [4], Leishmania major, L. donovani [5] and
Plasmodium falciparum [6], were lacking a functional RNAi pathway.
On the other hand, the genome sequence of L. (Viannia) braziliensis
[7] predicted the existence of the RNAi pathway in this leishmania
subgenus, and this prediction was recently experimentally
validated [8]. The realization that T. cruzi and old world
leishmanias are RNAi-negative was quite unfortunate, but it has
been argued that once the core genes involved in T. brucei RNAi
are identified it might be possible to try to reconstruct the pathway
in RNAi-negative trypanosomatids [1]. Indeed, the recent success
of David Bartel’s group in reconstructing the RNAi pathway in S.
cerevisiae [9] provides a proof of principle and informs us that it is
realistic to try to achieve the same goal in T. cruzi or old world
Leishmania sp.
Comparison of RNAi mechanisms in different model organisms
[10] suggests that the common, minimal machinery consisted of
firstly, a Dicer endonuclease of the RNase III family that processes
long dsRNAs into duplex small interfering RNAs (siRNAs) with
characteristic two-nucleotide 39 overhangs; secondly, an Argo-
naute (AGO) ‘‘slicer’’ endonuclease that in a complex with a
PLoS Pathogens | www.plospathogens.org 1 May 2012 | Volume 8 | Issue 5 | e1002678single-stranded (ss) guide siRNA (as opposed to the passenger
strand that is discarded) cleaves target mRNA; and thirdly, a Dicer
cofactor with a dsRNA-binding domain that facilitates siRNA
biogenesis and loading into AGO. The AGO-siRNA complex
forms the catalytic engine of the RNA-induced silencing complex
or RISC [11]. An additional factor found only in some RNAi-
proficient organisms is an RNA-dependent RNA polymerase [12]
that creates secondary siRNAs to amplify the initial RNAi
response.
The players identified so far in T. brucei RNAi are a single AGO
slicer, TbAGO1 [13,14], and two Dicer homologs, TbDCL1 [15]
and TbDCL2 [16]. This set of genes is also present in L. (V)
braziliensis [8], although their precise function needs to be
experimentally addressed. In T. brucei we have provided evidence
that the nuclear Dicer TbDCL2 is the first line of defence against
dsRNAs originating from retroposons (ingi and SLACS) and
satellite-like repeats (CIR147), whereas in the cytoplasm TbDCL1
processes intermediate-sized dsRNA molecules generated by
TbDCL2, as well as dsRNA that may escape from the nucleus
or enter the cytoplasm from the exterior milieu [15,16]. The RISC
loading mechanism in T. brucei is not known; no RNAi-specific
dsRNA-binding protein has been identified yet [17]. In Drosophila
[18,19] and Neurospora [20] it has been shown that mutations of
AGO slicer catalytic residues prevent cleavage of both the siRNA
passenger strand and the target RNA, and siRNAs associated with
the corresponding AGO are double-stranded. In contrast,
mutations that affect target RNA degradation by TbAGO1 in vivo
do not affect the maturation of siRNAs from duplex to single-
stranded form and TbAGO1 is associated with single-stranded
siRNAs [21,22].
The above observations hinted at an additional activity involved
in the formation of the TbAGO1/ss-siRNA complex. To test this
hypothesis we compared the genomes of RNAi-proficient
trypanosomatid protozoa with those that have lost the RNAi
machinery. In addition to the three characterized RNAi proteins
in T. brucei, we identified two novel factors, both of which we have
shown to be active in RNAi. RNA Interference Factor 5 (TbRIF5)
is required for cytoplasmic, but not nuclear RNAi, and appears to
act in conjunction with TbDCL1. TbRIF4 contains a C-terminal
domain related to 39-59 exonucleases of the DnaQ superfamily. In
the absence of TbRIF4 protein or function, duplex siRNAs
accumulate, and are not associated with TbAGO1. Human AGO2
can replace both TbRIF4 and TbAGO1 functions, suggesting that
the slicing function of human AGO2 in RISC maturation is
replaced in trypanosomes by the TbRIF4 exonuclease.
Results
TbRIF4 and TbRIF5 are two novel T. brucei RNAi factors
identified by comparative genomics
In order to identify the core RNAi genes we compared the
genomes of RNAi-deficient (T. cruzi and L. major) and RNAi-
proficient (T. brucei, T. congolense and L. braziliensis) trypanosomatids
and selected ORFs that are exclusively present in all the RNAi-
positive organisms, but absent from the RNAi-negative parasites.
This analysis only returned five genes. In addition to TbAGO1,
TbDCL1 and TbDCL2, the search identified two putative RNAi
factors (Tb927.10.8880 and Tb927.10.10730 in T. brucei), which
we named T. brucei RNA Interference Factor 4 and 5 (TbRIF4,
490 amino acids long, and TbRIF5, 1509 amino acids long).
At the primary sequence level the C-terminus of TbRIF4
contains a domain that resembles the DnaQ superfamily of 39-59
exonucleases (Figure 1). This structural feature is shared with
Neurospora crassa QIP (QDE2 Interacting Protein), which functions
in removal of the passenger strand siRNA fragments, after it has
been cleaved by the AGO slicer NcQDE2 [20]. This protein family
is characterized by three motifs encompassing the active site
residues DEDDh that are present in TbRIF4, as noted in a
bioinformatic screen by Trudeau and colleagues [23]. The active
site residues are conserved in all RIF4 homologs identified in
RNAi-proficient trypanosomatids (Figure S1A) and using the
alignment interface of SWISS-MODEL [24], structural predictions
(Figure S1B) revealed significant similarity with the exonuclease
Author Summary
RNA interference (RNAi), a naturally-occurring pathway
whereby the presence of double-stranded RNA in a cell
triggers the degradation of homologous mRNA, has been
harnessed in many organisms as an invaluable molecular
biology tool to interrogate gene function. Although this
technology is widely used in the protozoan parasite
Trypanosoma brucei, other parasites of considerable public
health significance, such as Trypanosoma cruzi, Leishmania
major, and Plasmodium falciparum do not perform RNAi.
Since RNAi has recently been introduced into budding
yeast, this opens up the possibility that RNAi can be
reconstituted in these pathogens. The key to this is getting
a handle on the essential RNAi factors in T. brucei.B y
applying comparative genomics we identified five genes
that are present in the RNAi-proficient species, but not in
RNAi-deficient species: three previously identified RNAi
factors, and two novel ones, which are described here. This
insight into the core T. brucei RNAi machinery represents a
major step towards transferring this pathway to RNAi-
deficient parasites.
Figure 1. Characteristics of TbRIF4. Schematic representation of TbRIF4 (the drawing is not to scale) and alignment of the three motifs
characteristic of 39-59 exonucleases of the DEDDh superfamily from E. coli DnaQ [25], N. crassa QIP [20], and T. brucei RIF4. Asterisks and bold
characters indicate conserved residues.
doi:10.1371/journal.ppat.1002678.g001
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NcQIP do not share any other sequence similarity. TbRIF5 is
specific to the trypanosomatid lineage and bioinformatic analysis
did not reveal any known domains (Figure S2).
TbRIF4 is essential for RNAi in both the cytoplasm and the
nucleus. First, rif4
2/2 cells (Figure S3A) had a much reduced
ability to respond to transfection with a-tubulin dsRNA (Table 1,
Figure 2A), an assay that monitors the cytoplasmic RNAi response
and in wild-type cells results in degradation of a-tubulin mRNA.
Second, in rif4
2/2 cells the levels of long and heterogeneous
repeat-derived (CIR147) transcripts were substantially increased as
compared to wild-type cells (Figure 2B, lane 2, and Figure 2C, lane
3), a previously-reported hallmark of nuclear RNAi deficiency
[16]. A TbRIF4-GFP cassette, integrated into the tubulin locus of
rif4
2/2 cells (rif4c cell line, Figure S3A), restored TbRIF4 levels
and complemented the mutant phenotypes, leading to wild-type
response to dsRNA transfection (Table 1, Figure 2A) and
restoration of long retroposon- and repeat-derived transcript levels
(Figure 2B, lane 3, and Figure 2C, lane 4). Consistent with the
involvement of TbRIF4 in both the nuclear and cytoplasmic arms
of the RNAi pathway, the TbRIF4-GFP fusion protein was
distributed uniformly between the nucleus and cytoplasm
(Figure 2D).
TbRIF5, on the other hand, only appears to be required for the
cytoplasmic branch of the RNAi pathway. rif5
2/2 cells (Figure
S3B) transfected with double-stranded a-tubulin RNA showed a
severe defect in the cytoplasmic RNAi response (Table 1).
However, levels of CIR147 transcripts were not increased by
TbRIF5 ablation (Figure 2B, lane 7), suggesting that nuclear RNAi
was unaffected. A TbRIF5-BB2-HA cassette, integrated into the
tubulin locus of rif5
2/2 cells (rif5c cell line, Figure S3B),
complemented the cytoplasmic RNAi defect (Table 1). Due to
the low level of expression of the epitope-tagged protein, the
cellular localization of TbRIF5 could not be ascertained by IFA.
However, cell fractionation experiments indicated that most of the
protein partitioned in the cytoplasm (data not shown).
TbRIF4 functions downstream of the dicer step of RNAi,
while TbRIF5 acts with TbDCL1
To determine the stage in the RNAi pathway at which TbRIF4
and TbRIF5 act, we first asked whether siRNAs were produced in
their absence. Northern blot analysis revealed that in rif4
2/2 cells
(Figure 3A, lane 2) ingi- and CIR147-derived siRNAs accumulat-
ed to levels greater than wild-type (lane 1) or rif4c (lane 3)
trypanosomes, although their size distribution was more hetero-
geneous than in wild-type cells, possibly due to nuclease nibbling
as these siRNAs are not associated with TbAGO1 (see below). An
in vitro dicing assay programmed with long dsRNA [16] indicated
that siRNA processing was as active in rif4
2/2 as in wild-type cell
extracts (Figure 3B), suggesting that TbRIF4 acts downstream of
the dicing step.
siRNAs also accumulated in rif5
2/2 parasites. However, as in a
dcl1
2/2 cell line [16], while siRNAs derived from the CIR147
tandem repeats accumulated in rif5
2/2 cells to a level comparable
to wild-type or rif5c trypanosomes (Figure 3A), SLACS retroposon
siRNA levels were reduced in the mutant cell line (lane 5), but
were restored by complementation (lane 6). A similar phenotype
was observed for the ingi-derived siRNAs (data not shown). These
data suggested a link to the cytoplasmic Dicer and the following
experiments provided corroborating evidence. Firstly, the in vitro
dicing assay showed that the siRNAs generated by a rif5
2/2 cell
extract were the same size as those created by a dcl1
2/2 extract,
which, as has been shown previously by our group, are one
nucleotide smaller than those generated by a dcl2
2/2 extract ([16];
Figure 3B). Secondly, we co-immunoprecipitated the two proteins
(Figure S4) and found that a proportion of TbDCL1 is in a
complex with TbRIF5. We expressed TbDCL1-BB2-FLAG and
TbRIF5-BB2-HA in the same cell line. Immunoprecipitation of
TbDCL1 (top panel) or TbRIF5 (bottom panel) was carried out
using anti-FLAG or anti-HA antibodies, respectively, and the fate
of both TbDCL1 and TbRIF5 was monitored by Western blotting
for the common BB2 epitope. It should be noted that TbDCL1-
BB2-FLAG is at least two to three times more abundant than
TbRIF5-BB2-HA in this cell line (see input lane in Figure S4).
When TbDCL1 was pulled down, the majority of TbRIF5 was
found in the immunoprecipitated fraction. In contrast, when
TbRIF5 was immunoprecipitated, approximately 50% of TbDCL1
was detected in the precipitate, in agreement with the lower
abundance of TbRIF5 (the identity of the immunoprecipitated
proteins was verified by Western blotting with HA monoclonal
antibody for TbRIF5, or FLAG monoclonal antibody for
TbDCL1; data not shown). The interaction of these two factors
was further supported by: i. co-fractionation on a Superdex-200
sizing column; ii. mass-spectrometry of FLAG-immunoprecipitat-
ed TbDCL1, which revealed several peptides derived from
TbRIF5 as well as TbDCL1 (data not shown). Thus, we concluded
that TbDCL1 and TbRIF5 interact either directly or indirectly.
siRNAs in TbRIF4 null trypanosomes accumulate in
duplex form
An essential step in the RNAi pathway is the formation of the
RNA-induced silencing complex or RISC [26], consisting of an
AGO ‘‘slicer’’, an endonuclease of the RNase H family, in a
complex with an siRNA, which guides target cleavage by AGO.
Biochemical studies have shown that human and Drosophila AGO2
are initially loaded with duplex siRNAs and, following passenger
strand nicking by AGO, the resulting fragments dissociate [27].
Specific factors required for this transition have been identified,
such as the multimeric endonuclease C3PO (Component 3
Promoter of RISC) in Drosophila and humans [28,29] or the
Neurospora 39-59 exonuclease QIP [20,30,31]. Thus, to test whether
TbRIF4 and/or TbRIF5 were involved in RISC formation, we
next asked whether the rif4
2/2- and rif5
2/2-derived siRNAs were
single- or double-stranded. We purified RNA from wild-type,
rif4
2/2, rif4c, rif5
2/2, and rif5c S100 extracts and analyzed the
samples on a native polyacrylamide gel with or without





Cell line 0 mg1 mg2 mg5 mg
wt ,53 9 5 6 1 0 0
rif4
2/2 ,5 ,5 ,5 ,5
rif4c ,54 0 4 7 9 4
rif5
2/2 ,5 ,5 ,5 ,5
rif5c ,52 5 3 7 9 3
ago1
2/2 ,5 ,5 ,5 ,5
Cell lines were transfected with the indicated amounts of dsRNA. The FAT cell
phenotype was scored 16 hr post-transfection and is represented as % FAT
cells; the response of wild-type cells transfected with 5 mg dsRNA was set at
100% and the values for the other cell lines were normalized accordingly. For
each cell line the experiments were repeated three times, and the average value
is shown.
doi:10.1371/journal.ppat.1002678.t001
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stranded synthetic siRNA was used as a control (lanes 7 and 8).
Following Northern blot hybridization with a CIR147 probe, most
siRNAs from wild-type cells appeared single-stranded (lane 1, see
[22]). A similar result was obtained with siRNAs from rif5
2/2 and
rif5c cells (lanes 11 and 13). In contrast, by this analysis non-
denatured rif4
2/2-derived siRNAs displayed the mobility expected
for duplex molecules (compare lanes 3 and 7), but were converted
Figure 2. Analysis of TbRIF4- and TbRIF5-mutant cell lines. (A) Response of rif4
2/2 cells and cells expressing TbRIF4 catalytic mutants or
HsAGO2 to transfection of a-tubulin dsRNA. Cells were electroporated with different amounts (in micrograms) of a-tubulin dsRNA, as indicated above
each lane or with 5 mg poly(I-C) (first lane in each panel set), and total RNA was prepared 2 h after electroporation and analyzed by Northern
hybridization with an a-tubulin-specific probe (a-tubulin panels). a-tubulin mRNA hybridization was quantitated by PhosphorImager analysis,
normalized to the load control and expressed as % mRNA remaining, setting as 100% the amount of a-tubulin mRNA present in the samples that
received poly(I-C). Load; hybridization to fumarate hydratase mRNA. (B) Steady-state levels of repeat-derived (CIR147) transcripts are increased in
rif4
2/2 cells but not rif5
2/2 cells. Total RNA isolated from various cell lines, as indicated above each lane, was analyzed by Northern hybridization with
a CIR147-specific probe. Load; hybridization to a-tubulin mRNA. Filled squares indicate the positions of the large ribosomal RNAs, as determined by
methylene blue staining of the membranes. (C) Semi-quantitative RT-PCR analysis of CIR147 transcript levels. cDNA derived from various cell lines (as
indicated above each lane; lanes 1–10) was used as a template for 22 cycles of PCR using oligonucleotides that amplify the CIR147 tandem repeat
transcripts, producing a ladder of fragments (top two panels), or a portion of histone H4 (bottom two panels). Dilutions of genomic DNA were used
as a positive control and an indicator for non-saturated PCR (lanes 11–13); mock cDNA synthesis without reverse transcriptase (second and fourth
panels, -RT) served as a negative control. (D) Cells were visualized using differential interference microscopy (DIC), GFP imaging, and Hoechst (Nucleus
and Kinetoplast are indicated by N and K, respectively); GFP and Hoechst images were merged (merge).
doi:10.1371/journal.ppat.1002678.g002
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rif4c sample again reproduced the single-stranded nature present
in wild-type cells (lane 5).
To provide additional evidence that siRNAs isolated from rif4
2/2
trypanosomes were double-stranded, we incubated the RNA
samples at different temperatures (20u to 100uC) prior to loading
them on a native gel (Figure S5A). Ingi siRNA strands dissociated
between 60uCa n d6 5 uC, consistent with a duplex structure. Lastly,
we assessed the sensitivity of siRNAs isolated from wild-type and
rif4
2/2 cells to treatment with RNase T1 and RNase A, which
preferentially cleave ss RNA in high salt (Figure S5B). Wild-type
CIR147 siRNAs were mostly degraded by the ribonucleases (lane 2),
with trace amounts resistant to digestion, but siRNAs derived from
rif4
2/2 cells were largely resistant to degradation (lane 5) and were
only cleaved efficiently following denaturation (lane 6).
The above results strongly indicated that rif4
2/2 siRNAs are
predominantly in duplex form. We think it is unlikely that the
duplex siRNAs are an artefact of the RNA isolation procedure,
since very little duplex siRNA can be observed in wild-type
samples prepared under the same conditions (Figure 3C, lane 1).
We showed previously by Northern blotting [32] that both sense
and antisense siRNAs from the retroposons ingi and SLACS
accumulate in T. brucei. Recent deep-sequencing of siRNAs
associated with TbAGO1 confirmed these early observations and
extended them to include CIR147 (unpublished observations).
Although wild-type siRNAs have the potential to anneal to form
Figure 3. Analysis of siRNAs in rif4
2/2 and rif5
2/2 backgrounds. (A) Steady-state siRNA levels in rif4
2/2 and rif5
2/2 cells. Low-molecular
weight RNAs were separated by denaturing gel electrophoresis and analyzed by Northern hybridization with an ingi-, SLACS- or CIR147-specific
probe, as indicated next to each panel. Load; hybridization to 5S rRNA. 26 nt, DNA marker. (B) Dicing is unaffected in ago1
2/2 and rif4
2/2 T. brucei
extracts, but shows an altered pattern in rif5
2/2 extracts. Whole cell extracts from cell lines, as indicated above the lanes, or buffer alone (2) were
incubated with a 83-nt, internally labelled dsRNA substrate. After incubation the products of digestion were separated on a denaturing
polyacrylamide gel. Size marker positions are indicated. (C) Native gel analysis of siRNAs from rif4
2/2 and rif5
2/2 cells. Low molecular weight RNAs
isolated from various cell lines, as indicated above each lane, were resolved on a native polyacrylamide gel without (2) or with (+) heating the
samples to 100uC for 2 minutes prior to electrophoresis and analyzed by Northern blotting with a CIR147 probe. A radiolabelled synthetic RNA was
included as a control (lanes 7 and 8). Load; hybridization to 5S rRNA.
doi:10.1371/journal.ppat.1002678.g003
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experimental conditions used.
siRNAs are not associated with TbAGO1 in TbRIF4 null cells
Next we asked whether siRNAs in rif4
2/2 cells were associated
with TbAGO1. To this end, we introduced TAP-tagged TbAGO1,
which fully complements TbAGO1 deficiency [14], into rif4
2/2
cells. It should be noted that the level of TAP-tagged TbAGO1
was much lower in rif4
2/2 cells as compared to wild-type
trypanosomes (Figure 4A, top panel, compare lanes 4 and 8). This
dramatic diminution of TbAGO1 levels was also observed for
endogenous TbAGO1 in rif4
2/2 cells (Figure 4B, middle panel,
compare lanes 1 and 2), but returned to normal upon comple-
mentation (lane 3). By semi-quantitative Western blot analysis we
estimated that the level of endogenous TbAGO1 was reduced
approximately 20-fold in rif4
2/2 cells (data not shown).
TAP-tagged TbAGO1 was immunoprecipitated from wild-type
and rif4
2/2 S100 extracts and varying amounts from the different
samples were analysed by Western (Figure 4A, top panel) or
Northern blotting (middle panel). This experiment showed that
when roughly similar amounts of TbAGO1 protein were loaded
(compare 90% of the immunoprecipitated material from rif4
2/2
cells with 9% or even 1% of the material from the wild-type
sample), no siRNAs could be detected in the pellet from the rif4
2/2
sample (lanes 6–8), although these molecules were clearly visible in




Biochemical investigation of TbRIF4 exonuclease activity
Our experiments so far suggested that TbRIF4 plays a role in
the conversion of double- to single-stranded siRNAs. To test
whether the predicted 39-59 exonuclease domain in the C-terminus
of TbRIF4 was involved in this process, we generated recombinant
GST-TbRIF4 fusion proteins (Figure S6A) and tested its activity in
vitro. Incubation of 25-nt duplex a-tubulin siRNA-315 [16],
labelled at the 59 end of the sense strand, with increasing amounts
of GST-TbRIF4 produced a distinct ladder of fragments that
progressively decreased in size with increasing protein concentra-
tion (Figure 5A, lanes 4–11) and with time (Figure S6B, lanes 2–7).
Mutation of conserved exonuclease active site residue H472 to
alanine drastically reduced the detected exonuclease activity
(Figure 5A, lane 12 and Figure S6B, lane 8). With the above
substrate we observed accumulation of a 7-nt fragment, but this
was not the case when the antisense strand of the duplex substrate
was labelled (Figure S6C), indicating that digestion by TbRIF4 is
somewhat affected by the substrate sequence. Nevertheless, these
results suggested that in vitro both strands are accessible to TbRIF4
digestion and that the enzyme has a distributive rather than
processive mode of action.
To further characterize TbRIF4 activity, we first used substrates
with no, single or double 39 nucleotide overhang (the label was
placed at the 59 end of the sense strand) and found that they were
also processed, suggesting that the 2-nt 39 extension is not
important for substrate recognition by recombinant TbRIF4 in vitro
(Figure S6D), consistent with a distributive mode of action.
Secondly, we showed that recombinant TbRIF4 acted preferen-
Figure 4. siRNAs are not associated with TbAGO1 in rif4
2/2 cells. (A) Cytoplasmic extracts from cells expressing TAP-tagged TbAGO1 in a wild-
type (lanes 1–4) or rif4
2/2 (lanes 5–8) background were immunoprecipitated with IgG beads, and the indicated amounts of supernatant (S, lanes 1
and 5) and immunoprecipitated material (P, lanes 2–4 and 6–8) were analyzed by Western blotting with a polyclonal anti-TbAGO1 antibody (upper
panel, TbAGO1). CIR147 siRNAs in the soluble and precipitated materials were revealed by Northern hybridization (middle panel, CIR147 siRNA). RNA
loading was quantified by hybridization to 5S rRNA (bottom panel, 5S RNA). (B) TbRIF4 and TbAGO1 steady-state levels in various cell lines. Total
protein extracts from 5610
6 cells from various cell lines, as indicated above each lane, were resolved by SDS-PAGE and Western blotted with a
polyclonal anti-TbRIF4 antibody (top panel, TbRIF4) or a polyclonal anti-TbAGO1 antibody (middle panel, TbAGO1). Load; a cross-reacting band to the
TbAGO1 antibody (bottom panel).
doi:10.1371/journal.ppat.1002678.g004
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and that catalysis required magnesium ions (Figure S6F) and a free
39 end (Figure S6G), as processing of the RNA substrate was
inhibited by EDTA or by blocking the 39 end with a 29,39-
dideoxycytosine, respectively. Thirdly, we asked whether GST-
TbRIF4 can convert the RNA duplex into ss-RNA. Recombinant
TbRIF4 does not exhibit clear strand selectivity (Figure S6C), thus
either strand can be degraded and any released ssRNA will base-
pair with available complementary products to form dsRNA. To
circumvent this problem, we carried out an in vitro assay where one
strand of the double-stranded RNA substrate was labelled at the 59
end and the 39 end of the same strand was blocked by dideoxy-C
to prevent it from being a substrate for TbRIF4 (Figure 5B). This
mimics the effect of a bound protein protecting one end of the
duplex, a likely in vivo scenario. The products of this reaction were
separated on a native gel, showing that many of the molecules had
been converted to the single-stranded form. Thus, TbRIF4 has an
intrinsic 39-59 exonuclease activity in vitro, which acts preferentially
on double-stranded RNA, and its activity is dependent on a
predicted active site residue.
Active site residues are important for TbRIF4 function
in vivo
Next we assessed whether TbRIF4’s conserved DnaQ exonu-
clease family DEDDh residues (Figure 1) were essential for in vivo
function by mutating each amino acid to alanine in the context of
the TbRIF4-GFP complementation cassette, and introducing the
resulting mutants into rif4
2/2 cells. With the exception of mutant
E296A (Figure 4B, lane 5), the other proteins (D294A, D392A,
H472A and D477A, lanes 4, 6, 7 and 8) were expressed close to
the level of wild-type TbRIF4-GFP (lane 3). Upon transfection of
5 mg a-tubulin dsRNA, which in wild-type cells results in
approximately 84% degradation of target mRNA, in cells lacking
TbRIF4 or expressing mutants D294A, D392A or H472A there
was very low or no detectable degradation of a-tubulin mRNA
(Figure 2A). In contrast, transfection of dsRNA into cells
expressing mutant D477A showed that at each dsRNA concen-
tration tested, the cytoplasmic RNAi efficiency was reduced about
50% as compared to the wild-type level. Thus, it appeared that the
D477 residue is not as important as the other predicted catalytic
residues for TbRIF4 activity in vivo. However, our results indicated
that mutation of residues D294, D392 and H472 severely
impaired the ability of cells to respond to dsRNA transfection.
Similarly, nuclear RNAi as measured by RT-PCR of CIR147
repeats was partially restored in cells expressing mutant D477A
(Figure 2C, lane 8), in agreement with the results of Figure 2A,
whereas cells expressing mutants D294A, D392A and H472A
appeared significantly impaired in nuclear RNAi (lanes 5–7).
Finally, expression of active-site TbRIF4 mutants D294A, D392A,
H472A and D477A failed to restore TbAGO1 to wild-type levels
(Figure 4B, middle panel, lanes 4–8), although the amount of
TbAGO1 was increased as compared to rif4
2/2 cells.
TbRIF4 is part of a complex containing TbAGO1 and siRNAs
The finding that siRNAs were not detectably associated with
TbAGO1 in rif4
2/2 cells could indicate a physical interaction
between the two proteins. To test this hypothesis, we performed
immunoprecipitations. Pull-downs of either wild-type or H472A
TbRIF4-GFP revealed the presence of TbAGO1 in the immuno-
precipitates (Figure 6A), with more TbAGO1 in the H472A
TbRIF4-GFP sample compared to the wild-type sample (compare
lanes 3 and 6, bottom panel). We next asked whether siRNAs could
be immunoprecipitated with wild-type or H472A TbRIF4-GFP
(Figure 6B). In cells expressing wild-type TbRIF4-GFP, CIR147
siRNAs were below the limit of detection (lane 2). In contrast, a
fraction of CIR147 siRNAs were found in the immunoprecipitated
material after pull-down of H472A TbRIF4-GFP (lane 4). These
results indicated that a proportion of a catalytically inactive TbRIF4
was in a complex containing TbAGO1 and siRNAs. We take these
results as supportive evidence that TbRIF4 and TbAGO1 interact in
vivo, either directly or indirectly, and that the interaction can be
stabilized by mutation of the TbRIF4 exonuclease active site,
although the significance of the latter observation remains to be
investigated further.
Figure 5. Recombinant TbRIF4 39-59 exonuclease activity in vitro. (A) Titration of GST-RIF4 activity. 1 pmol of a 25 nt-long, 59-end labelled
synthetic dsRNA was incubated with 0.01–30 pmol GST-RIF4 (lanes 4–11; molar ratios from 10:1 to 1:30) or 30 pmol GST-TbRIF4 carrying mutation
H472A (lane 12). Lane 3, input. AH, alkaline hydrolysate ladder. M, marker oligonucleotides. Samples were separated on a denaturing 20%
polyacrylamide gel. (B) Action of GST-TbRIF4 on a RNA substrate blocked at the 39 end of one strand. 1 pmol of a 25 nt-long, 59-end labelled synthetic
dsRNA with a dideoxycytosine residue at the 39 end of the labelled strand was incubated with 0.03–30 pmol GST-TbRIF4 (lanes 3–6), or buffer alone
(lanes 1 and 2). Samples were separated on a non-denaturing 16% polyacrylamide gel. As a control for the separation of double-stranded and single-
stranded species, the substrate incubated with buffer alone was resolved on the same gel without (lane 1, native) or with (lane 2, denat.) heating to
100uC for 2 minutes prior to electrophoresis.
doi:10.1371/journal.ppat.1002678.g005
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in passenger strand removal
Our past and present data indicated that the transition from ds-
to ss-siRNAs in T. brucei is uncoupled from TbAGO1 slicer
function and is carried out by the TbRIF4 exonuclease. We
previously reported that human AGO2 slicer (HsAGO2), but not
HsAGO1, which lacks target transcript slicing activity, can
partially complement TbAGO1 null cells [17]. Since HsAGO2
slicing activity is involved in the cleavage of both the passenger
strand of duplex siRNAs and the target RNA [27,33], we
hypothesized that the restoration of the RNAi response by
HsAGO2 may occur by a TbRIF4-independent mechanism. Thus,
HA-FLAG-tagged HsAGO2 was introduced into rif4
2/2:ago1
2/2
cells. Expression of HsAGO2 resulted ina partial cytoplasmic RNAi
response measured by transfection with dsRNA (Figure 2A), as
previously described for cells expressing HsAGO2 and TbRIF4, but
nuclear RNAi was not restored (Figure 2C, lane 9), as evidenced by
the accumulation of CIR147 transcripts. To monitor the physical
state of the siRNAs, HsAGO2 was immunoprecipitated and the
associated siRNAs were analyzed by native gel electrophoresis
(Figure 6C). In agreement with the partial RNAi response, a
fraction of the siRNAs was single-stranded (lane 3). These results
indicated that in trypanosomes expressing HsAGO2 maturation of
siRNAs from duplex- to ss-form, takes place independently of
TbRIF4 and underscored a model where TbRIF4 in a complex with
TbAGO1 degrades the siRNA passenger strand, thus substituting
for HsAGO2 passenger cleavage activity in ss-siRNA biogenesis in
T. brucei.
Discussion
The availability of genome sequences from trypanosomatids
that are either RNAi proficient or not, provided us with an
opportunity to tease out genes specific to the RNAi mechanism.
Quite surprisingly, the comparative genomics analysis revealed a
limited set of five genes: the previously characterized TbAGO1,
TbDCL1 and TbDCL2, as well two additional candidates, TbRIF4
and TbRIF5. Here, we showed that both TbRIF4 and TbRIF5 are
essential for RNAi, and carry out distinct functions. TbRIF4 is
implicated in the formation of a stable TbAGO1/guide siRNA
complex through conversion of duplex siRNAs to their single-
Figure 6. Interaction between TbRIF4, TbAGO1 and siRNAs. (A) Cytoplasmic extracts from rif4
2/2 cells expressing wt TbRIF4-GFP (lanes 1–3) or
mutant H472A TbRIF4-GFP (lanes 4–6) were subjected to immunoprecipitation with anti-GFP antibody. 0.1% of the supernatant (S, lanes 1 and 4),
0.1% (lanes 2 and 5) and 0.4% (lanes 3 and 6) of the immunoprecipitated material were analyzed by Western blotting with a polyclonal anti-RIF4
antibody (top panel) or a polyclonal anti-TbAGO1 antibody (bottom panel). The efficiency of immunoprecipitation is shown in the antibody titration
experiment in Figure S7. (B) The presence of CIR147 siRNAs in the various samples as described in panel (A) was analyzed by Northern blot
hybridization with a CIR147 probe. Load; hybridization to 5S rRNA. (C) Immunoprecipitated HsAGO2 is associated with duplex and single-stranded
siRNAs. Cytoplasmic extracts from cell lines expressing HA-FLAG-HsAGO2 in an ago1
2/2:rif4
2/2 genetic background, were immunoprecipitated with
anti-FLAG antibodies. RNA associated with HsAGO2 was separated on a native polyacrylamide gel and subjected to Northern hybridization with a
CIR147 probe (upper panel). Total RNA from rif4
2/2 trypanosomes was used as a control for the position of duplex siRNAs (T, lane 1). Load;
hybridization to 5S rRNA (middle panel). Equal amounts of the supernatant (S, lane 2) and immunoprecipitated material (P, lane 3) were analyzed by
Western blotting with anti-HA antibody (HsAGO2 panel).
doi:10.1371/journal.ppat.1002678.g006
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due to a lack of recognizable domains, but this factor appears to be
working in concert with TbDCL1. The latter conclusion is based
on the observations that TbRIF5’s ablation resulted in cytoplasmic
RNAi deficiency and that the protein associated with TbDCL1,
the cytoplasmic Dicer. We therefore propose a role for TbRIF5 as
a cofactor in TbDCL1-mediated processing of long dsRNA. It is
unlikely that TbRIF5 is involved in nuclear RNAi as CIR147
siRNAs, which are generated by TbDCL2, are not affected by
TbRIF5 ablation, and we have recently shown that RNAi of small
nucleolar RNAs similarly requires TbDCL2, but is independent of
TbDCL1 [34]. The specific reduction of SLACS and ingi siRNAs
in TbRIF5 null cells points to the possibility that TbRIF5 is
required at some point in the biogenesis of such siRNAs in the
cytoplasm, either by stimulating TbDCL1 cleavage activity and/or
by functioning as a bridge between TbDCL1, the siRNAs and
TbAGO1. RNase III enzymes, such as Dicer and Drosha, in
general require the assistance of dsRBP cofactors [12]. For
instance, in Drosophila R2D2 forms a complex with DCR-2,
enhances the incorporation of siRNAs into RISC [35] and acts as
a sensor for strand asymmetry of siRNAs [36]. In human cells the
interaction of DGCR8 with Drosha is essential for excision of pre-
miRNAs from primary miRNA containing transcripts [37].
Although TbRIF5 lacks a recognizable dsRNA binding domain,
it may be that such a motif exists but is highly divergent.
TbRIF4 contains a predicted 39-59 exonuclease domain. In vivo
TbRIF4 knockout results in both nuclear and cytoplasmic RNAi
deficiency and in the accumulation of duplex siRNAs that are not
detectably associated with TbAGO1 by co-immunoprecipitations.
As predicted from its domain structure, TbRIF4-GST is endowed
with in vitro 39-59 exonuclease activity, and processes duplex
siRNAs. Complementation of rif4
2/2 cells with TbRIF4-GFP
carrying mutations of catalytic residues D294A, D392A and
H472A, which also impair exonuclease activity in vitro (data not
shown), did not restore RNAi competency of TbRIF4 null cells,
indicating that TbRIF4 catalytic activity is required for RNAi
function.
TbRIF4 and TbAGO1 interact, either directly or indirectly, and
form a complex that can be recovered in greater amounts from
mutant H472A TbRIF4-GFP than from wild-type cells and
contains a small proportion of siRNAs. Although at present it is
unclear how this observation relates to TbRIF4 function, it
indicates that mutant TbRIF4 becomes ‘‘stuck’’ in a complex with
TbAGO1. It is possible that the interaction between the two wild-
type proteins is transient and that after the siRNA is converted to
single-stranded form within this complex (either before or after
loading into TbAGO1), TbRIF4 dissociates from TbAGO1.
TbRIF4 on its own does not appear to show any strand selectivity;
therefore, the strand removed is possibly determined by the
orientation in which the duplex is presented by Dicer, as has been
reported in Drosophila [38]. The use of chaperone proteins, for
example heat shock proteins, in RISC loading has been reported
in higher eukaryotes [39–42]. It is possible that TbRIF4 acts in this
way in addition to its role as an exonuclease.
We also observed that TbAGO1 levels are diminished in cells
lacking functional TbRIF4. However, we note that there was no
straightforward correlation between the amount of TbAGO1
present in the various mutant cell lines and their degree of RNAi
competency, suggesting that catalytically impaired TbRIF4s can to
some extent promote TbAGO1 accumulation through a mecha-
nism that is presently unknown. As TbAGO1 mRNA levels are
only marginally affected by TbRIF4 deletion (data not shown),
either TbAGO1 translation is severely inhibited or the protein is
made and rapidly degraded. So far inhibition of the proteasome
and lysosome degradation pathways has not restored TbAGO1
levels (unpublished observations), pointing to the possibility that
translational control regulates the amount of TbAGO1 that is
synthesized.
T. brucei RIF4 shares with Neurospora QIP a C-terminal 39-59
exonuclease domain of the DnaQ superfamily. Although both
proteins are essential RNAi factors and interact with the
corresponding Argonaute, they are functionally distinct in several
respects. First, in Neurospora qip
ko cells duplex siRNAs are stably
loaded into the AGO homolog QDE-2 and, after QDE-2 slicer-
mediated cleavage of the passenger strand, remain bound to
QDE-2 in duplex, nicked form [20]. In contrast, siRNAs can be
successfully loaded into TbAGO1 and TbRIF4 can accomplish the
transition from double- to single-stranded siRNAs in the absence
of TbAGO1 slicer activity [21,22]. Secondly, we showed that
TbRIF4 activity is required for TbAGO1 protein accumulation.
This finding is not mirrored in Neurospora or Drosophila, where
mutation of passenger strand fragment removal factors QIP or
C3PO has no effect on the corresponding AGO levels [20,28]. In
light of these data, it is evident that TbRIF4 and NcQIP are
functionally distinct RNAi factors.
In trypanosomes expressing HsAGO2, maturation of siRNAs
takes place independently of TbRIF4, suggesting a model where
TbRIF4 substitutes for AGO slicing activity in the generation of ss-
siRNAs. This would represent a departure from strategies of RISC
maturation in higher eukaryotes, which favor slicer activity
marking the passenger strand for degradation, although bypass
pathways can operate in the absence of slicer activity [27,43,44].
Taken together with our earlier studies, the results presented
here provide a detailed depiction of the core RNAi machinery in
the early divergent parasitic protozoan T. brucei. In these
organisms, the RNAi pathway is initiated by two distinct Dicer-
like enzymes, namely TbDCL1, mostly found in the cytoplasm
[15], and TbDCL2, a mainly nuclear Dicer responsible for
processing dsRNAs originating from retroposons and satellite-like
repeats [16]. siRNAs generated by both Dicers are channelled into
a single member of the Argonaute family of proteins, namely
TbAGO1 [13,14]. The identification and characterization of
TbRIF4 and TbRIF5 most likely completes the collection of core
components shared by RNAi-positive trypanosomatids. However,
it is likely that, as described in other organisms, other cellular
factors interact with the core RNAi machinery. Some of these
factors may perform housekeeping functions, for instance the
Hsp90/70 family of chaperons that functions in RISC assembly in
higher eukaryotes, and be present in all trypanosomatids
irrespective of their RNAi proficiency, while others may be
organism-specific. Indeed, we have recently discovered that the T.
brucei homologue of the plant HEN1 29-O methyltransferase [45] is
required for siRNA 39 end modification (unpublished observation).
However, siRNA modification is not an absolute requirement for
trypanosomatid RNAi, as in L. braziliensis the HEN1 gene is
absent, and deletion of TbHEN1 is still compatible with a robust
RNAi response (unpublished observations). It could be argued at
this point that attempting to reconstitute RNAi in RNAi-deficient
pathogens is quite daunting with a minimum of five core
components. However, our past and current mechanistic studies
have highlighted that not all components are necessary. In
particular, we have shown previously that TbDCL2-deficient cells
are more responsive to RNAi triggers than wild-type cells [16]
suggesting that this factor does not need to be included in a
reconstitution attempt. In addition, in the present study we have
shown that human AGO2 can functionally replace both TbAGO1
and TbRIF4, indicating that the TbRIF4 function can be bypassed
by using an appropriate AGO protein. It will be interesting to see
T. brucei RNAi Factors
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factor remaining a mystery is TbRIF5 and its function will be
challenging to ascertain due to a complete lack of a possible
functional indicator. Nevertheless, the available proof of principle
that RNAi can be reconstituted in S. cerevisiae by using only AGO1
and DCR1 from S. castelli [9] in combination with our functional
studies raises the intriguing possibility that a similar strategy might
be applicable in RNAi-negative trypanosomatids.
Materials and Methods
Standard methods
Previously published procedures were followed for culturing
trypanosome YTat 1.1 cells [46], generation of knockout cell lines
by PCR-based methods [47], Northern blots of total RNA [32],
Western blots [14], S100 preparation [32], immunoprecipitations
[14], and the Dicer in vitro assay [16].
RT-PCR
5 mg of total RNA from various cell lines was treated with 2
units of DNase RQ (Promega), phenol extracted and ethanol
precipitated. DNase-treated RNA was used in a reverse transcrip-
tion reaction using the manufacturer’s protocol for the Superscript
II enzyme (Invitrogen), phenol extracted, ethanol precipitated, and
resuspended in 100 ml water. Mock reactions without the reverse
transcriptase enzyme were carried out in parallel. 22 cycles of
PCR were performed using the Phusion enzyme (Finnzyme) and
the GC buffer provided, according to manufacturer’s instructions:
50uC annealing temperature, 10 sec extension time for the
CIR147 reactions, 30 sec extension time for the histone 4
reactions.
Preparation of small RNAs
Small RNAs were extracted from S100 extracts by incubation in
polysome buffer plus 20 mM EDTA, 2% SDS and 0.1 mg/ml
proteinase K for 1 hour at room temperature. An equal volume of
phenol and 1/10 volume 206SET [pH 7.4] were added and the
mixture was centrifuged at 13,2006g for 5 min. The supernatant
was incubated with 600 ml isopropanol and 30 mg GlycoBlue
(Ambion) at 220uC for 30 min and centrifuged at 13,2006g for
10 min at 4uC. The pellet was washed with 70% ethanol, dried
and resuspended in water (for native gels) or urea loading buffer
(for denaturing gels). RNA was transferred to a positively-charged
nylon membrane (Hybond N+, GE Healthcare) and UV cross-
linked at 120 mJ/cm
2. The membrane was incubated in boiling
water, which was allowed to cool to room temperature, twice prior
to probe hybridization. This treatment significantly improved
detection of dsRNA.
Preparation of probes
DNA oligos were 59 end-labelled with T4 polynucleotide kinase
(NEB) using [c-
32P]ATP and purified using P6 columns (BioRad).
Hybridizations were carried out in ExpressHyb solution (Clontech)
overnight at 30uC. Washes in 26 SSC, 0.2% SDS were carried
out at room temperature. Blots were analyzed by PhosphorIma-
ger.
Purification of recombinant protein
TbRIF4 was cloned into the pGEX4T-1 vector. Inductions of
500 ml DH5a bacteria were carried out by adding 0.2 mM
isopropyl b-D-1-thiogalactopyranoside (IPTG) overnight at 16uC.
Cells were washed in PBS containing protease inhibitors, lysed by
sonication in 5 ml PBS containing protease inhibitors and GST-
TbRIF4 was purified using a SpinTrap column (GE). Proteins
were eluted in 50 mM Tris-HCl [pH 8.0], 10 mM glutathione,
before being applied to a desalting column and stored in assay
buffer (20 mM HEPES-KOH [pH 7.9], 150 mM sucrose, 20 mM
potassium L-glutamate, 3 mM MgCl2, 2 mM DTT).
Exonuclease assays
Exonuclease assays were carried out for 30 min at 28uCi n1 0ml
assay buffer including RNase Inhibitor (Roche) and 0.01 mg/ml
bovine tRNA. Reactions were terminated by the addition of 46
SET, 20 mM EDTA, 30 mg GlycoBlue and isopropanol, stored at
220uC for 30 min and spun at 13,2006g for 10 min at 4uC. The
pellet was washed with 70% ethanol, dried and resuspended in
urea loading buffer. Samples were resolved on a 20% denaturing
polyacrylamide gel and analyzed by PhosphorImager.
Supporting Information
Figure S1 TbRIF4 sequence analysis. (A) Sequence align-
ment of TbRIF4 protein sequences from T. brucei (Tbru), T.
congolense (Tcon), T. vivax (Tviv) and L. (V.) braziliensis (Lbra) created
using ClustalX (www.clustal.org) and shaded using boxshade
(http://www.ch.embnet.org/software/BOX_form.html). Con-
served motifs are outlined, and conserved active site residues are
indicated by asterisks. (B) Ribbon diagram of the secondary
structure of E. coli DnaQ (left) adapted from [25] and of the
predicted model of the exonuclease domain of TbRIF4 (right)
using the alignment interface of SWISS-MODEL [24].
(TIF)
Figure S2 TbRIF5 sequence analysis. Sequence alignment
of TbRIF5 protein sequences from T. brucei (Tbru), T. congolense
(Tcon), T. vivax (Tviv) and L. (V.) braziliensis (Lbra) created using
ClustalX (www.clustal.org) and shaded using boxshade (http://
www.ch.embnet.org/software/BOX_form.html).
(TIF)
Figure S3 TbRIF4 and TbRIF5 knockout and comple-
mentation cell lines. (A) rif4
2/2 cells do not express TbRIF4
mRNA (top panel) or protein (bottom panel). Total RNA isolated
from various cell lines, as indicated above each lane, was resolved
by formaldehyde-agarose gel electrophoresis and analyzed by
Northern blot hybridization with a TbRIF4-specific probe (top
panel). Load; a-tubulin hybridization. Total protein extracts were
resolved by SDS-PAGE and probed with a polyclonal anti-
TbRIF4 antibody (third panel). Load; a cross-reacting band. (B)
rif5
2/2 cells do not express TbRIF5 mRNA (top panel). Total
RNA isolated from various cell lines, as indicated above each lane,
was resolved by formaldehyde-agarose gel electrophoresis and
analyzed by Northern blot hybridization with a RIF5-specific
probe (top panel). Load; a-tubulin hybridization. Ten-fold less
RNA was loaded in the rif5c lane compared to the other two lanes.
(TIF)
Figure S4 Physical association of TbDCL1 and TbRIF5.
Cytoplasmic extracts from rif4
2/2 cells expressing DCL1-FLAG-
BB2 and RIF5-HA-BB2 were subjected to immunoprecipitation
with anti-FLAG antibody (upper panel) or anti-HA antibody
(lower panel). Equal numbers of cell equivalents of the input (I),
supernatant (S), and immunoprecipitated material (P) were
analyzed by Western blotting with a monoclonal anti-BB2
antibody.
(TIF)
Figure S5 siRNAs in rif4
2/2 trypanosomes are double-
stranded. (A) Native gel analysis of siRNAs in rif4
2/2 cells. RNA
isolated from a rif4
2/2 S100 extract was resolved on a native
T. brucei RNAi Factors
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temperatures as indicated above each lane for 2 minutes prior to
electrophoresis and analyzed by Northern blotting with an ingi
probe. (B) siRNAs in rif4
2/2 cells are protected from digestion
with RNase. S100-derived RNAs from wild-type (lanes 1–3) and
rif4
2/2 (lanes 4–6) cells were treated with RNase T1 (5 U/ml) and
RNase A (20 mg/ml) for 1 hr at 25uC, either without (lanes 2 and
5) or with (lanes 3 and 6) denaturation by boiling prior to enzyme
addition. RNAs incubated with buffer alone (lanes 1 and 4) were
included as a control. Following digestion with proteinase K, the
samples were electrophoresed on a 16% denaturing gel and
analyzed by Northern hybridization with a CIR147 probe (top
panel). Load; hybridization to 5S rRNA (bottom panel).
(TIF)
Figure S6 Recombinant TbRIF4 39-59 exonuclease activ-
ity in vitro. (A) Purification of GST-TbRIF4. 30 pmol of
recombinant GST-TbRIF4 was resolved by SDS-PAGE and
stained with Coomassie Brilliant Blue. (B) Time-course of GST-
TbRIF4 activity. 1 pmol of a 25 nt-long, 59-end labelled synthetic
dsRNA was incubated with 30 pmol GST-RIF4 for 1 to 30 min
(lanes 2–7). The activity of GST-TbRIF4 carrying mutation
H472A incubated for 30 min is shown in lane 8, and a no-protein
control is in lane 1. (C) GST-TbRIF4 activity is not restricted to
one of the duplex RNA strands. 1 pmol of synthetic siRNA-315
labelled at the 59 end of either the ‘‘sense’’ or ‘‘antisense’’ strand
was incubated with wild-type GST-TbRIF4 (wt; lanes 2 and 5),
GST-TbRIF4 carrying mutation H472A (H472A; lanes 3 and 6)
or buffer alone (lanes 1 and 4). (D) Action of GST-TbRIF4 on
siRNA-like substrates with shorter 39 overhangs. 1 pmol of a
25 nt-long, 59-end labelled synthetic dsRNA with 39 overhangs of
2, 1 or 0 nt was incubated with 0.04 to 25 pmol GST-TbRIF4
(lanes 2–6, 8–12 and 14–18) or buffer alone (lanes 1, 7 and 13). (E)
GST-TbRIF4 preferentially cleaves double-stranded RNA. 1 pmol
synthetic ssRNA (lanes 1 and 2) or dsRNA (lanes 3 and 4) was
incubated with (+; lanes 2 and 4) or without (2; lanes 1 and 3)
30 pmol wild-type GST-TbRIF4. (F) GST-TbRIF4 activity is
abolished by addition of EDTA. 1 pmol synthetic dsRNA was
incubated with 30 pmol wild-type GST-RIF4 (wt; lanes 2 and 5),
GST-TbRIF4 carrying mutation H472A (H472A; lanes 3 and 6)
or buffer alone (lanes 1 and 4). 5 mM EDTA was added in the
reactions for lanes 4–6. (G) GST-TbRIF4 activity requires a free 39
end. 1 pmol synthetic dsRNA either without (lanes 1–3) or with
(lanes 4–6) a terminal 29,39-dideoxycytidine residue was incubated
with 30 pmol GST-TbRIF4 (wt; lanes 2 and 5), GST-TbRIF4
carrying mutation H472A (H472A; lanes 3 and 6) or buffer alone
(lanes 1 and 4).
(TIF)
Figure S7 Efficient pull-down of TbRIF4-GFP. Cytoplas-
mic extracts from rif4
2/2 cells expressing wt TbRIF4-GFP were
subjected to immunoprecipitation with anti-GFP antibody. Equal
volumes of the input (I), supernatant (S) and immunoprecipitated
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